A detailed history of American Research & Management Co. transactions in Pfizer Inc stock. As of the latest transaction made, American Research & Management Co. holds 31,230 shares of PFE stock, worth $835,090. This represents 0.38% of its overall portfolio holdings.

Number of Shares
31,230
Previous 31,630 1.26%
Holding current value
$835,090
Previous $1.66 Million 17.55%
% of portfolio
0.38%
Previous 0.43%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 07, 2022

SELL
$43.76 - $53.42 $17,504 - $21,368
-400 Reduced 1.26%
31,230 $1.37 Million
Q2 2022

Jul 22, 2022

SELL
$46.53 - $55.17 $68,631 - $81,375
-1,475 Reduced 4.46%
31,630 $1.66 Million
Q1 2022

Apr 21, 2022

SELL
$45.75 - $56.69 $15,417 - $19,104
-337 Reduced 1.01%
33,105 $1.71 Million
Q4 2021

Jan 28, 2022

BUY
$41.32 - $61.25 $12,767 - $18,926
309 Added 0.93%
33,442 $1.98 Million
Q3 2021

Oct 28, 2021

SELL
$39.25 - $50.42 $26,376 - $33,882
-672 Reduced 1.99%
33,133 $1.43 Million
Q2 2021

Jul 16, 2021

SELL
$35.91 - $40.68 $104,929 - $118,866
-2,922 Reduced 7.96%
33,805 $1.32 Million
Q4 2020

Jan 28, 2021

BUY
$33.47 - $42.56 $3,347 - $4,256
100 Added 0.27%
36,727 $1.35 Million
Q3 2020

Oct 29, 2020

SELL
$31.75 - $37.25 $7,937 - $9,312
-250 Reduced 0.68%
36,627 $1.34 Million
Q2 2020

Jul 28, 2020

SELL
$30.12 - $36.54 $11,295 - $13,702
-375 Reduced 1.01%
36,877 $1.21 Million
Q1 2020

Apr 28, 2020

SELL
$27.03 - $38.62 $40,545 - $57,929
-1,500 Reduced 3.87%
37,252 $1.22 Million
Q4 2019

Jan 17, 2020

SELL
$32.92 - $37.36 $250,192 - $283,936
-7,600 Reduced 16.4%
38,752 $1.52 Million
Q3 2019

Oct 31, 2019

SELL
$32.49 - $42.13 $20,468 - $26,541
-630 Reduced 1.34%
46,352 $1.67 Million
Q2 2019

Jul 18, 2019

SELL
$36.98 - $41.52 $53,768 - $60,370
-1,454 Reduced 3.0%
46,982 $2.04 Million
Q1 2019

Apr 16, 2019

BUY
$37.5 - $41.2 $132,975 - $146,095
3,546 Added 7.9%
48,436 $2.06 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $3,847 - $4,386
-100 Reduced 0.22%
44,890 $1.96 Million
Q3 2018

Oct 04, 2018

SELL
$34.47 - $41.81 $31,505 - $38,214
-914 Reduced 1.99%
44,990 $1.98 Million
Q2 2018

Jul 25, 2018

BUY
$32.98 - $35.16 $519,797 - $554,156
15,761 Added 52.29%
45,904 $1.67 Million
Q1 2018

Apr 19, 2018

SELL
$31.91 - $37.02 $12,604 - $14,622
-395 Reduced 1.29%
30,143 $1.07 Million
Q4 2017

Feb 08, 2018

SELL
$33.26 - $35.29 $148,306 - $157,358
-4,459 Reduced 12.74%
30,538 $1.11 Million
Q3 2017

Oct 17, 2017

BUY
$31.0 - $34.15 $1.08 Million - $1.2 Million
34,997
34,997 $1.25 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track American Research & Management Co. Portfolio

Follow American Research & Management Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.